About the Authors

Kevin A. Kwei

Affiliation Genomic Health, Inc., Redwood City, California, United States of America

Joffre B. Baker

Affiliation Genomic Health, Inc., Redwood City, California, United States of America

Robert J. Pelham

rpelham@genomichealth.com

Affiliation Genomic Health, Inc., Redwood City, California, United States of America

Competing Interests

Genomic Health, Inc. provided funding for this work. All the authors are paid employees of Genomic Health, Inc., own stock in the company, and are inventors named in an United States patent application (assigned to Genomic Health, Inc.) describing methods to identify biomarkers predictive of patient response to targeted chemotherapies, including GDC-0941 and NVP-BEZ235. This does not alter adherence by the authors or Genomic Health, Inc. to all PLOS ONE policies on sharing data and materials. No other competing interests, personal or financial, exist.

Author Contributions

Conceived and designed the experiments: KAK RJP. Performed the experiments: KAK RJP. Analyzed the data: KAK JBB RJP. Wrote the paper: KAK JBB RJP.